A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Status:
Recruiting

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

The main objective of this study is to evaluate safety and efficacy of ALS-L1023 in patients with Non-alcoholic steatohepatitis

Phase 2

AngioLab, Inc.